Jennison Associates LLC Novavax Inc Transaction History

Jennison Associates LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$134.56 - $217.97 $19.3 Million - $31.2 Million	-143,362 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$177.8 - $270.58 $4.08 Million - $6.21 Million	22,964 Added 19.07%	143,362 $29.7 Million
Q2 2021 Aug 12, 2021	SELL	$121.0 - $257.67 $9.42 Million - $20.1 Million	-77,852 Reduced 39.27%	120,398 $25.6 Million
Q1 2021 May 11, 2021	SELL	$112.98 - $319.93 $2.93 Million - $8.3 Million	-25,947 Reduced 11.57%	198,250 $35.9 Million
Q4 2020 Feb 05, 2021	BUY	$78.74 - $139.5 $6.22 Million - $11 Million	79,028 Added 54.44%	224,197 $25 Million
Q3 2020 Nov 04, 2020	BUY	$79.44 - $178.51 $11.5 Million - $25.9 Million	145,169 New	145,169 $15.7 Million

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $704M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.